B HALL STRATEGIES, LLC

Lobbying for TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS · Biopharmaceutical company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · Senate · $30,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Medicare/Medicaid

Issues related to Orphan drug coverage under Medicare. General Medicare issues impacting Jazz Pharmaceuticals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.